DAOYAN WEI to Antibodies, Monoclonal
This is a "connection" page, showing publications DAOYAN WEI has written about Antibodies, Monoclonal.
Connection Strength
0.111
-
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target. Stem Cells Transl Med. 2015 Sep; 4(9):1033-43.
Score: 0.051
-
Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. Int J Oncol. 2008 Jul; 33(1):161-7.
Score: 0.031
-
Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Cancer Res. 2007 May 15; 67(10):4878-85.
Score: 0.029